Digital Health Global

MARCH 2, 2023

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Lloyd Price

NOVEMBER 21, 2023

By implementing these strategies, Palantir can effectively address public concerns, build trust, and gain acceptance for its role in delivering the NHS Federated Data Platform, ultimately contributing to improved patient care and healthcare outcomes in England. Palantir's products are used by a variety of industries, including healthcare.

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Digital Health Global

JUNE 13, 2023

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Lloyd Price

MAY 2, 2024

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

healthcare technology 56

healthcare technology Drug Development Leadership Digital Health 56

Lloyd Price

FEBRUARY 18, 2024

Mergers and acquisitions: The promising future of GLP-1s led to several mergers and acquisitions within the healthtech industry. These deals aimed to consolidate market share, expand research capabilities, and accelerate product development, further stimulating investor interest.

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Lloyd Price

FEBRUARY 2, 2024

Benefits for healthcare stakeholders: Streamlined patient onboarding: Verifiable credentials from SSI wallets can expedite patient registration and verification, reducing administrative burdens and improving wait times. Regulatory frameworks and industry-wide collaboration are key drivers.

Health Data 64

Health Data Interoperability healthcare technology Leadership 64

Healthcare IT Today

NOVEMBER 14, 2022

Brad Whitmore is a successful investor who has targeted a broad range of investments across various industries with an emphasis on businesses with long-term, sustainable competitive advantages and unique offerings relative to competitors. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

Life Science 95

Life Science HIPAA Drug Development healthcare technology 95